Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of ...
A psychoactive ingredient found in ayahuasca, a brew used in shamanistic rituals in South America, has shown promise as a treatment for depression in a phase 2a trial. In the study, 34 people living ...
SAN FRANCISCO — If they’re starving, the best minds of this generation can order $19.50 lobster rolls at the former site of the Six Gallery in San Francisco. Today, it houses Tacko, where customers ...
It's a kick into the weekend. A fresh, eclectic choice of dance music from all over the world. You may hear cumbia or bluegrass or afrobeat or jazz, but it'll keep your head a-noddin' and your spirits ...
With clinical trials for its novel psychedelic drug underway, trailblazing neuropharma company Small Pharma is exploring a novel path to better mental health. Psychedelics gained notoriety as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results